News

Constellation Brands to Announce Q3 Fiscal 2025 Results Soon

Constellation Brands to Announce Q3 Fiscal 2025 Results Soon

Upcoming Financial Report from Constellation Brands

Constellation Brands, Inc. (NYSE: STZ), a recognized leader in the beverage alcohol sector, has announced its plans to release financial results focusing on the third quarter ending November 30, 2024. This key financial disclosure is scheduled for January 9, 2025, ahead of the U.S. market's opening.

Details of the Conference Call

The company will host a conference call at 10:30 a.m. ET on the same day, allowing stakeholders to gain insights into the financial outcomes and future projections. Bill Newlands, the President and Chief Executive Officer, alongside Garth Hankinson, the Executive Vice President and Chief Financial Officer, will lead the discussion. Stakeholders are encouraged to join the call by dialing +1-877-407-9121 and providing the conference ID number 13750414, accessible from 10:20 a.m. ET.

Those unable to attend the call live can access a replay afterward on the company’s investor relations webpage. Notably, detailed financial information presented during this event will also be made available to the public through the same platform, enhancing transparency.

About Constellation Brands

Constellation Brands (NYSE: STZ) is an esteemed international producer and marketer of a diverse range of beverages, including beer, wine, and spirits. The company's operational reach extends across various regions—including the U.S., Mexico, New Zealand, and Italy—and it remains committed to its mission of elevating human connections through beloved brands. Constellation Brands believes in the importance of labor and calculated risk-taking to anticipate market trends and deliver enhanced value for all its stakeholders.

High-Quality Products and Portfolio

The beverage portfolio includes prestigious brands such as Corona Extra and Modelo Especial, accompanied by an impressive range of craft spirits, fine wines, and premium brands like Kim Crawford and Meiomi. Delivering high-quality products is at the heart of the company's strategy, enabling it to maintain its competitive edge in the beverage marketplace.

Sustainable and Responsible Practices

Constellation Brands recognizes its responsibility as an agriculture-based company and has implemented sustainable practices throughout its operations. The company’s ESG strategy reflects its commitment to environmental stewardship, social equity, and the promotion of responsible consumption of alcoholic beverages. These principles guide the company’s operations as it strives for a brighter future.

Media and Investor Contacts

For those seeking further information, the media and investor relations teams at Constellation Brands are available for inquiries. The media contacts include:

  • Amy Martin: 585-678-7141 / amy.martin@cbrands.com
  • Carissa Guzski: 315-525-7362 / carissa.guzski@cbrands.com

The investor relations contacts include:

  • Joseph Suarez: 773-551-4397 / joseph.suarez@cbrands.com
  • Snehal Shah: 847-385-4940 / snehal.shah@cbrands.com
  • David Paccapaniccia: 585-282-7227 / david.paccapaniccia@cbrands.com

Frequently Asked Questions

What is the purpose of the upcoming conference call?

The conference call is intended to discuss Constellation Brands' financial results for the third quarter of fiscal 2025 and provide insights on future outlook.

When will the financial results be released?

The financial results will be released on January 9, 2025, before the U.S. markets open.

Who will lead the conference call?

Bill Newlands, the CEO, and Garth Hankinson, the CFO, will lead the conference call.

How can I access the conference call?

Participants can join the call by dialing +1-877-407-9121 and entering the conference identification number 13750414.

Is there a way to access the information if I miss the call?

Yes, a replay will be available on the company’s investor relations website for those who cannot attend the call live.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles